← FDA Drug Approvals (Drugs@FDA)

DOXERCALCIFEROL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA · Approved 2022-01-24

Drug application

FDA Application #

ANDA213717

Application type

Abbreviated New Drug Application (Generic)

Brand name

DOXERCALCIFEROL

Generic name

DOXERCALCIFEROL

Active ingredients

DOXERCALCIFEROL

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

EUGIA PHARMA

Manufacturer

Eugia US LLC

First approval

2022-01-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown